Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
Ward
S J
SJ
Department of Neurosciences, Sterling Research Group.
Baizman
E
E
Bell
M
M
Childers
S
S
D'Ambra
T
T
Eissenstat
M
M
Estep
K
K
Haycock
D
D
Howlett
A
A
Luttinger
D
D
D000588:Amines / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D048588:Benzoxazines; D002186:Cannabinoids / Q000378:metabolism / Q000494:pharmacology*; D003511:Cyclohexanols / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000378:metabolism; D007211:Indoles / Q000378:metabolism / Q000494:pharmacology*; D009025:Morpholines / Q000378:metabolism / Q000494:pharmacology*; D009281:Naphthalenes / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000187:drug effects*
D000588:Amines; D048588:Benzoxazines; D002186:Cannabinoids; D003511:Cyclohexanols; D007211:Indoles; D009025:Morpholines; D009281:Naphthalenes; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug; C070417:(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone; C054649:3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol; D019204:GTP-Binding Proteins; C062767:pravadoline